REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCadence Mineral Regulatory News (KDNC)

Share Price Information for Cadence Mineral (KDNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.75
Bid: 3.50
Ask: 4.00
Change: 0.00 (0.00%)
Spread: 0.50 (14.286%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.60
KDNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Sale of Yangibana JV Interest

25 Jan 2023 08:35

RNS Number : 8189N
Cadence Minerals PLC
25 January 2023
 

Cadence Minerals Plc

("Cadence Minerals", "Cadence", or "the Company")

 

Completion of Sale of Yangibana Joint Venture Interest to Hastings Technology Metals

 

Cadence Minerals (AIM/NEX: KDNC; OTC: KDNCY) is pleased to announce that it has completed the sale of its working interests in the Yangibana Rare Earths project ("Yangibana Project") tenements to Hastings Technology Metals (ASX: HAS) ("Hastings").

 

Highlights:

Ø Cadence has received AS$9 million of new ordinary shares in ASX-listed Hastings for its 30% stake in various tenements of the Yangibana Rare Earth Project

Ø Cadence has received some 2.45 million shares of Hastings, roughly 1.9% of the issued share capital of Hastings

Ø Hastings is constructing the world's next producer of neodymium and praseodymium concentrate, with maiden production forecast to start in 2024

Ø NPV of project AS$ 1 billion, Hastings current market capitalisation AS$472 million (24/01/2023)

Further transaction details are available in Company's RNS dated 23 June 2022 here. Cadence has sold its 30% working interest in the Yangibana Project tenements to the operator and owner of the remainder of the Yangibana Project, Hastings, for A$9 million (£5.1 million), which has been satisfied via the issue of 2,452,650 new ordinary shares in Hastings to Cadence. These shares represent approximately 1.9% of the current issued share capital of Hastings Technology and are subject to a 12-month voluntary escrow. As of 31 December 2021, the total carrying values of the tenements in the Company's balance sheet was approximately £905,000. Based on the transaction announced, the initial profits on the sale of our interest is approximately £4.2 million.

 

About Hastings

Hastings is a well-managed Perth-based rare earths company primed to become the world's next producer of neodymium and praseodymium concentrate (NdPr). NdPr are vital components used to manufacture permanent magnets used daily in advanced technology products ranging from electric vehicles to wind turbines, robotics, medical applications and digital devices.

 

Hastings' flagship Yangibana project, in the Gascoyne region of Western Australia, contains a highly valued NdPr deposit with NdPr: TREO ratio of up to 52%. The site is permitted for long-life production and with offtake contracts signed and debt finance in an advanced stage. Construction has commenced, and Hastings is planning to start commissioning the beneficiation plant in late 2023, with the delivery of maiden production to key customers in 2024.

 

In February of last year, Hastings published a revised NPV calculation, which increased the NPV by 84% to AS$ 1 billion. Hastings also owns and operates the Brockman project, Australia's largest heavy rare earths deposit, near Halls Creek in the Kimberley. For further information on the Company and its projects, visit www.hastingstechmetals.com

 

For further information contact:

 

Cadence Minerals plc

+44 (0) 20 3582 6636

Andrew Suckling

Kiran Morzaria

WH Ireland Limited (NOMAD & Broker)

+44 (0) 207 220 1666

James Joyce

Darshan Patel

- Ends -

 

Qualified Person

Kiran Morzaria B.Eng. (ACSM), MBA, has reviewed and approved the information contained in this announcement. Kiran holds a Bachelor of Engineering (Industrial Geology) from the Camborne School of Mines and an MBA (Finance) from CASS Business School.

 

Forward-Looking Statements:

Certain statements in this announcement are or may be deemed to be forward-looking statements. Forward-looking statements are identied by their use of terms and phrases such as ''believe'' ''could'' "should" ''envisage'' ''estimate'' ''intend'' ''may'' ''plan'' ''will'' or the negative of those variations or comparable expressions including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth results of operations performance future capital and other expenditures (including the amount. nature and sources of funding thereof) competitive advantages business prospects and opportunities. Such forward-looking statements reect the Directors' current beliefs and assumptions and are based on information currently available to the Directors. Many factors could cause actual results to differ materially from the results discussed in the forward-looking statements including risks associated with vulnerability to general economic and business conditions competition environmental and other regulatory changes actions by governmental authorities the availability of capital markets reliance on key personnel uninsured and underinsured losses and other factors many of which are beyond the control of the Company. Although any forward-looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions. The Company cannot assure investors that actual results will be consistent with such forward-looking statements.

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFIFVTLSIEFIV
Date   Source Headline
31st Oct 20229:00 amRNSInvestment Update
7th Oct 20227:00 amRNSMineral Resource Increase & Upgrade Amapá Project
28th Sep 20227:00 amRNSInterim Results for six months ended 30 June 2022
10th Aug 20223:50 pmRNSResult of AGM
12th Jul 20227:00 amRNSDirector Share Purchases
7th Jul 20222:58 pmRNSNotice of AGM
27th Jun 20227:00 amRNSCompletion of LT & LS sale & Amapa Project Update
23rd Jun 20227:00 amRNSSale of Yangibana JV Interest to Hastings
21st Jun 20227:00 amRNSAnnual Results for the year ended 31 December 2021
25th Apr 20228:53 amRNS4th Amapa Iron Ore Shipment Completed & En Route
19th Apr 20227:00 amRNSExercise of Warrants
11th Apr 202211:14 amRNSDirector Share Purchases
7th Apr 20229:50 amRNSCommencement of Shipment of Iron Ore from Amapa
30th Mar 20227:00 amRNSConditional Sale Agreement of its Stake in LT & LS
21st Mar 20227:00 amRNSPFS Update for the Amapa Project
15th Mar 20229:28 amRNSCadence completes to vest its 27% in Amapa Project
21st Feb 20223:42 pmRNSResult of Open Offer
21st Feb 20227:00 amRNSYangibana Project NPV Increases 84% to A$1bn
7th Feb 20227:00 amRNSAmapa - Formal Completion & Vesting of 20%
4th Feb 20221:45 pmRNSOpen Offer and Posting of Circular
3rd Feb 20229:05 amRNSSecond Price Monitoring Extn
3rd Feb 20229:00 amRNSPrice Monitoring Extension
3rd Feb 20227:00 amRNSResult of Placing & Subscription and TVR
2nd Feb 20224:40 pmRNSProposed Placing
2nd Feb 20221:54 pmRNSNAIF A$140m Loan - Yangibana Rare Earths Project
19th Jan 20222:05 pmRNSEMH Cinovec PFS Update - Outstanding Results
14th Jan 20227:00 amRNSProject & Corporate Updates. Presentation Q&A
5th Jan 20227:00 amRNSQuestions for Investor Q&A Session
29th Dec 202111:06 amRNSSecond Price Monitoring Extn
29th Dec 202111:00 amRNSPrice Monitoring Extension
29th Dec 20219:06 amRNSSecond Price Monitoring Extn
29th Dec 20219:00 amRNSPrice Monitoring Extension
29th Dec 20217:00 amRNSAmapa Iron Ore Project Update
25th Nov 202111:45 amRNSCastillo Extends Option Over Lithium Projects
22nd Nov 20218:57 amRNSCastillo Copper Picasso Lithium Project Update
1st Nov 20219:01 amRNSPort Concession Update, Amapa Project
27th Oct 20219:50 amRNSCastillo - Picasso Lithium Project Site Visit
20th Oct 202111:43 amRNSLitchfield Lithium surface sampling by Castillo
13th Oct 202110:27 amRNSEuropean Metals Cinovec Resource Upgrade
11th Oct 202111:05 amRNSSecond Price Monitoring Extn
11th Oct 202111:00 amRNSPrice Monitoring Extension
11th Oct 20219:05 amRNSSecond Price Monitoring Extn
11th Oct 20219:00 amRNSPrice Monitoring Extension
11th Oct 20217:00 amRNSBank Credit Committee Approval for Amapa Project
7th Oct 202112:19 pmRNSCastillo Litchfield Lithium Due Diligence Update
29th Sep 20217:01 amRNSOption Granted to Castillo to Acquire Projects
26th Aug 202112:00 pmRNSInterim Results
25th Aug 20213:58 pmRNSMacarthur Lake Giles Feasibility Study Progress
23rd Aug 20217:00 amRNSMacarthur Lakes Giles Feasibility Study Progress
18th Aug 20213:06 pmRNSYangibana Rare Earth Joint Venture Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.